Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: J Hepatol. 2022 Jan 21;76(5):1100–1108. doi: 10.1016/j.jhep.2021.12.034

Figure 3 – Cox-adjusted Association between (A) Binary Statin Exposure, (B) Categorical Lipid Lowering Medications, and (C) Increasing Statin Dose Exposure* on Development of ACLF.

Figure 3 –

Abbreviations: LL = lipid lowering

* Time-updated dose exposures expressed in simvastatin equivalents